On October 16, Injective (INJ) rallied 27% to hit a peak of nearly $9.20, marking its highest valuation since October 2025. The price surge drove the altcoin's market capitalization past $920 million, securing its position as the 85th-largest cryptocurrency after surpassing Pi Network (PI).
Regulatory Engagement in Washington Sparks Rally
The price movement coincided with executive-level discussions in Washington, D.C. Injective Chief Executive Officer Eric Chen, accompanied by the team's General Counsel, Head of Policy, and Head of Research, held meetings with officials from the White House, the Securities and Exchange Commission (SEC), and the Commodity Futures Trading Commission (CFTC).
Following the talks, Injective announced on X that the team "has quietly built the foundation for tokenization to thrive in America, inside the regulatory framework and in direct collaboration with the U.S. government and major regulatory bodies."
According to data from CoinGecko, additional market drivers included an active staker vote on proposal IIP-709 to institute fixed gas fees, alongside reports that Injective's revenue-to-fully diluted valuation (revenue-to-FDV) ratio outpaced other prominent layer-1 blockchains.
Technical Targets and Market Indicators
- Regulatory Summit: CEO Eric Chen met with representatives from the White House, SEC, and CFTC.
- Market Valuation: INJ market cap exceeded $920 million, reaching rank #85.
- Overbought Indicator: Relative Strength Index (RSI) climbed to near 80.
Market analyst Ali Martinez noted that INJ completed a breakout from a cup-and-handle technical pattern with a 30% move, setting an upside target near $14. Analyst MikybullCrypto advised market participants to take note "before the train leaves," reiterating a previous chart projection of $80 based on historical trading setups.
Despite the bullish momentum, technical indicators signal potential short-term resistance. The token's RSI climbed to nearly 80, placing it above the standard 70 overbought threshold. X commentary from Crypto GVR cautioned: "After such a strong move, some volatility wouldn't be surprising. Let's see how INJ performs around the $9 level in the coming days."
Why It Matters
Injective's proactive engagement with U.S. federal agencies reflects an intensifying industry focus on compliant, institutional tokenization within existing legal structures. While an 80 RSI suggests the asset may encounter near-term cooling or consolidation around $9, direct dialogue with the SEC and CFTC offers fundamental backing that sets INJ apart from purely speculative market moves. Monitoring whether the protocol can sustain momentum toward the $14 technical target will provide key insight into market demand for regulatory-aligned altcoins.
